## Distinguishing Fibroadenoma from Malignancy **Key Point:** Fibroadenoma is a benign breast tumor with an extremely low malignant transformation risk, NOT >5% as suggested by the distractor. ### Characteristics of Fibroadenoma | Feature | Details | |---------|----------| | **Malignant Transformation Risk** | <1% (exceptionally rare; most sources cite 0.1–0.3%) | | **Clinical Presentation** | Painless, mobile, firm, well-circumscribed mass | | **Age of Onset** | Typically 15–35 years (reproductive years) | | **Growth Pattern** | Estrogen-dependent; may regress post-menopause | | **Histology** | Benign proliferation of epithelial and stromal components | | **Imaging (Ultrasound)** | Hypoechoic, homogeneous, well-defined margins | | **Imaging (Mammography)** | Oval, circumscribed, radiolucent mass | **High-Yield:** The distinction between fibroadenoma and phyllodes tumor is critical. Phyllodes tumors (especially malignant variants) have a higher transformation risk and show stromal hypercellularity and mitotic activity on histology. ### Why Malignant Transformation Risk is NOT >5% 1. **Epidemiological data** consistently show fibroadenoma has negligible malignant potential. 2. **Phyllodes tumors** (which CAN transform) are a separate entity with increased stromal cellularity and atypia. 3. **Benign fibroadenomas** require no routine excision unless symptomatic or causing cosmetic concern. **Clinical Pearl:** A fibroadenoma that shows rapid growth, skin changes, or imaging features suggesting stromal hypercellularity should raise suspicion for phyllodes tumor, not simple fibroadenoma malignant transformation. **Warning:** Do not confuse fibroadenoma (benign, <1% transformation) with phyllodes tumor (borderline/malignant variants with 10–40% transformation risk).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.